Acesion Pharma
VerifiedDevelops drugs for the treatment of atrial fibrillation.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$198—297m (Dealroom.co estimates Sep 2023.)
Company register number 34083738
Copenhagen Capital Region of Denmark (HQ)
| EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | $0.0 | round | |
| investor | $0.0 | round | |
| investor investor | $0.0 | round | |
| investor | $0.0 | round | |
| investor investor | $0.0 | round | |
* | €45.0m | Series B | |
| Total Funding | 000k | ||
Related Content
Recent News about Acesion Pharma
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.